UPXI:NASDAQUpexi, Inc. Analysis
Data as of 2026-07-15 - not real-time
$0.84
Latest Price
9/10Risk
Risk Level: High
Executive Summary
Upexi, Inc. (UPXI) is trading well below its short‑ and long‑term moving averages – the price of $0.84 sits under the 20‑day SMA (≈$0.85), the 50‑day SMA (≈$1.08) and the 200‑day SMA (≈$2.12), confirming a bearish technical backdrop. The RSI of 44.8 suggests the stock is not yet oversold, while the MACD shows a modest bullish histogram (+0.011) but the overall trend remains down‑trend with decreasing volume. Volatility is extreme at over 106% 30‑day, and a beta of ~4.5 indicates the stock moves dramatically more than the market, amplifying risk.
Fundamentally, the company is distressed: operating margins are –23%, EBITDA is heavily negative, cash flow is negative, and debt exceeds $242 million against a meager cash balance of $3.5 million. The price‑to‑earnings ratio of 1.44 looks cheap only because earnings are marginal, and the price‑to‑book is negative (‑1.08). No dividend is paid, and ROA is –1.27%. The recent inclusion in the Russell Microcap® Index may boost visibility, and the firm’s focus on a Solana‑based digital‑asset treasury adds crypto‑related regulatory uncertainty. Overall, the technical weakness, extreme volatility, and weak fundamentals outweigh the modest valuation allure.
Fundamentally, the company is distressed: operating margins are –23%, EBITDA is heavily negative, cash flow is negative, and debt exceeds $242 million against a meager cash balance of $3.5 million. The price‑to‑earnings ratio of 1.44 looks cheap only because earnings are marginal, and the price‑to‑book is negative (‑1.08). No dividend is paid, and ROA is –1.27%. The recent inclusion in the Russell Microcap® Index may boost visibility, and the firm’s focus on a Solana‑based digital‑asset treasury adds crypto‑related regulatory uncertainty. Overall, the technical weakness, extreme volatility, and weak fundamentals outweigh the modest valuation allure.
Market Outlook
Short Term
< 1 yearCautious
Model confidence: 8/10
Key Factors
- Price below all major SMAs indicating bearish momentum
- Decreasing volume and extreme 30‑day volatility
- Negative operating cash flow and high debt load
Medium Term
1–3 yearsNeutral
Model confidence: 5/10
Key Factors
- Potential institutional inflow from Russell Microcap index inclusion
- Crypto‑treasury exposure could improve if market sentiment shifts
- Continued earnings weakness and cash burn
Long Term
> 3 yearsCautious
Model confidence: 7/10
Key Factors
- Sustained negative profitability and deteriorating balance sheet
- High beta and volatility make risk‑adjusted returns unattractive
- Regulatory uncertainty surrounding digital‑asset activities
Key Metrics & Analysis
Financial Health
Revenue Growth44.20%
P/E Ratio1.4
ROA-126.53%
P/B Ratio-1.1
Op. Cash Flow$-21524226
Free Cash Flow$-229092160
Industry P/E16.2
Technical Analysis
TrendBearish
RSI44.8
Support$0.74
Resistance$1.12
MA 20$0.85
MA 50$1.08
MA 200$2.12
MACDBullish
VolumeDecreasing
Fear & Greed Index91.96
Valuation
Target Price$1.30
Upside/Downside55.28%
GradeOvervalued
TypeValue
Risk Assessment
Beta4.53
Volatility106.29%
Sector RiskMedium
Reg. RiskHigh
Geo RiskLow
Currency RiskLow
Liquidity RiskHigh
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.